Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Browsing: WHO-prequalification Africa
Medicines for Malaria Venture announces collaborative agreement with S Kant HEALTHCARE Ltd
Medicines for Malaria Venture (MMV) has established a new collaboration with S Kant HEALTHCARE Ltd…